$3.41T
Total marketcap
$122.93B
Total volume
BTC 61.09%     ETH 9.32%
Dominance

CFXA Stock

177.71 {{ price }} 0.000000% {{change_pct}}%
Exchange
NYSE
Market Cap
0
LOW - HIGH [24H]
-
VOLUME [24H]
0
{{ volume }}
P/E Ratio
0
Earnings per share
0

Price Chart

CFXA Financial and Trading Overview

stock price 177.71
Previous Close 180.1
Open 177.18
Bid 0 x 900
Ask 0 x 900
Day's Range 176.83 - 185.61
52 Week Range 153.73 - 212.81
Volume 182.49K
Avg. Volume 10.35K
Market Cap 4.57B
Beta (5Y Monthly) 2.172987
PE Ratio (TTM) 248.89357
EPS (TTM) 0
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

CFXA Valuation Measures

Enterprise Value 30.94B
Trailing P/E 248.89357
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.2499988
Price/Book (mrq) 5.997233
Enterprise Value/Revenue 8.455
Enterprise Value/EBITDA 53.405

Trading Information

Stock Price History

Beta (5Y Monthly) 2.172987
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 212.81
52 Week Low 153.73
50-Day Moving Average 189.08
200-Day Moving Average 189.04

CFXA Share Statistics

Avg. Volume (3 month) 10.35K
Avg. Daily Volume (10-Days) 11.84K
Shares Outstanding 117.2M
Float 137.58M
Short Ratio 38.7
% Held by Insiders 0%
% Held by Institutions 30.75%
Shares Short 41.45K
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate N/A
Trailing Annual Dividend Yield N/A
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2020
Most Recent Quarter (mrq) October 1, 2021
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin 2.91%
Operating Margin (ttm) 8.78%
Gross Margin 42.39%
EBITDA Margin 15.83%

Management Effectiveness

Return on Assets (ttm) 2.65%
Return on Equity (ttm) 3.18%

Income Statement

Revenue (ttm) 3.66B
Revenue Per Share (ttm) 24.84
Quarterly Revenue Growth (yoy) 19.80%
Gross Profit (ttm) N/A
EBITDA 579.32M
Net Income Avi to Common (ttm) 124.53M
Diluted EPS (ttm) 0.714
Quarterly Earnings Growth (yoy) 92.80%

Balance Sheet

Total Cash (mrq) 177.48M
Total Cash Per Share (mrq) 1.15
Total Debt (mrq) 1.79B
Total Debt/Equity (mrq) 38.64
Current Ratio (mrq) 1.769
Book Value Per Share (mrq) 29.632

Cash Flow Statement

Operating Cash Flow (ttm) 388.68M
Levered Free Cash Flow (ttm) 210.3M

Profile of

Country United States
State DE
City Wilmington
Address 2711 Centerville Road
ZIP 19808
Phone 302 252 9160
Website https://www.colfaxcorp.com
Industry Specialty Industrial Machinery
Sector(s) Industrials
Full Time Employees 15400

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is based in Wilmington, Delaware.

Q&A For Stock

What is a current CFXA stock price?

CFXA stock price today per share is 177.71 .

How to purchase stock?

You can buy CFXA shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ?

The stock symbol or ticker of is CFXA.

Which industry does the company belong to?

The industry is Specialty Industrial Machinery.

How many shares does have in circulation?

The max supply of shares is 0.

What is Price to Earnings Ratio (PE Ratio)?

PE Ratio is now.

What was earnings per share over the trailing 12 months (TTM)?

EPS is 0 over the trailing 12 months.

Which sector does the company belong to?

The sector is Industrials.

CFXA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NYSE Composite Index NYA 20199.49 USD
+0.4

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap